Alberta, Canada Clinical Investigator Site ‘Central Alberta Research Clinic’ Leads LEO Pharma Delgocitinib Study for Atopic Dermatitis

Alberta, Canada Clinical Investigator Site ‘Central Alberta Research Clinic’ Leads LEO Pharma Delgocitinib Study for Atopic Dermatitis

Central Alberta Research Clinic conducts a Phase II eczema clinical trial for an investigational cream-based treatment called Delgocitinib (Leo Pharma). The Alberta clinical investigator site is one of three sites in Canada as well as nine in the U.S. conducting the...

Pin It on Pinterest